Skip to search formSkip to main contentSkip to account menu

120 ACTUAT Budesonide 0.18 MG/ACTUAT Dry Powder Inhaler [Pulmicort]

Known as: Pulmicort Flexhaler 0.18 MG/ACTUAT (0.16 MG/ACTUAT from the mouthpiece) Dry Powder Inhaler, 120 ACTUAT, Pulmicort Flexhaler 180 MCG/ACTUAT Dry Powder Inhaler, 120 ACTUAT, Pulmicort Flexhaler 180 MCG/INHAL Dry Powder Inhaler, 120 ACTUAT 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
This work investigated the effect of relative humidity (RH) on bipolar electrostatic charge profiles of dry powder inhaler… 
2017
2017
BACKGROUND The fraction of exhaled nitric oxide (FeNO) and serum levels of the soluble receptor for advanced glycation end… 
2012
2012
Inhaled corticosteroids are considered to be an effective prophylactic against the morbid symptoms of several lung diseases, but… 
2011
2011
Background Inhaled corticosteroids provide unique systems for local treatment of asthma or chronic obstructive pulmonary disease… 
Highly Cited
2008
Highly Cited
2008
PurposeAt present, there is no published data examining the effect of relative humidity on the electrostatic charges of dry… 
Highly Cited
2004
Highly Cited
2004
A multicenter, randomized, open-label, crossover study with two 4-week evaluation periods compared patient preference and ease of… 
Review
2004
Review
2004
Asthma, a chronic and potentially life‐threatening disease of the airways, affects patients of all ages. Inhaled corticosteroids… 
2000
2000
BACKGROUND Dysphonia is a known local adverse effect of inhaled corticosteroids. This symptom was investigated by laryngoscopy… 
Highly Cited
1999
Highly Cited
1999
Topical corticosteroids are one of the main pillars in the treatment of nasal polyps. The exact topography of their intranasal…